Not applicableStudy completedNCT00898664What this trial is testingDNA Analysis of Tissue Samples From Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT03383094What this trial is testingChemoradiation vs Immunotherapy and Radiation for Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaCancerCancer of Head and Neck+12 more Loren Mell, MD 126
Not applicableLooking for participantsNCT05047094What this trial is testingAlpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCCWho this might be right forHead and Neck Squamous Cell CarcinomaSkin CancerMetastatic Head-and-neck Squamous-cell Carcinoma Alpha Tau Medical LTD. 48
Not applicableStudy completedNCT00984074What this trial is testingMRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck CancerWho this might be right forHead and Neck Cancer Abramson Cancer Center at Penn Medicine 3
Testing effectiveness (Phase 2)Study completedNCT00358930What this trial is testingARQ 501 in Patients With Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck NeoplasmsCarcinoma, Squamous Cell ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 60
Large-scale testing (Phase 3)Study completedNCT05523323What this trial is testingPembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China ExtensionWho this might be right forHead and Neck Squamous Cell Carcinoma Merck Sharp & Dohme LLC 112
Early research (Phase 1)Ended earlyNCT00023790What this trial is testingPhotodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinWho this might be right forBreast CancerHead and Neck CancerLymphoma+3 more Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03162224What this trial is testingSafety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck CancerWho this might be right forHead and Neck CancerHuman Papilloma Virus MedImmune LLC 35
Not applicableLooking for participantsNCT06356272What this trial is testingOropharynx (OPX) Biomarker TrialWho this might be right forClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Oropharyngeal Squamous Cell Carcinoma+8 more Mayo Clinic 560
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07751289What this trial is testingAnti-PD-1 Therapy in Recurrent and Metastatic Head and Neck Squamous Cell CarcinomaWho this might be right forRecurrent Head and Neck Squamous Cell Carcinoma Yanjie Zhang, MD 217
Testing effectiveness (Phase 2)Study completedNCT01252628What this trial is testingPhase 1 and 2 Study of PX-866 and CetuximabWho this might be right forIncurable Metastatic Colorectal CarcinomaIncurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cascadian Therapeutics Inc. 178
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 680
Testing effectiveness (Phase 2)UnknownNCT01377298What this trial is testingPazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma National Taiwan University Hospital 45
Testing effectiveness (Phase 2)WithdrawnNCT04093115What this trial is testingStudy of CX1106 in Patients With Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma Beijing Konruns Pharmaceutical Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT00116909What this trial is testingOSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line TherapyWho this might be right forLocally Recurrent or Metastatic Cancer of the Head and NeckMust Have Failed First-Line Therapy OSI Pharmaceuticals 85
Large-scale testing (Phase 3)Study completedNCT00002533What this trial is testingFluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerWho this might be right forHead and Neck CancerInfectionOral Complications University of Miami
Testing effectiveness (Phase 2)Study completedNCT00020189What this trial is testingFlavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck CancerThromboembolism National Cancer Institute (NCI)
Large-scale testing (Phase 3)WithdrawnNCT04129320What this trial is testingEnoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck CancerSquamous Cell Carcinoma of Head and Neck MacroGenics
Testing effectiveness (Phase 2)Ended earlyNCT00573989What this trial is testingIntensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck CancerWho this might be right forHead and Neck Cancer Wake Forest University Health Sciences 27
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130